# Immunogenicity of Rabies Vaccine for Pre Exposure Prophylaxis

> **NCT02374814** · PHASE4 · COMPLETED · sponsor: **State University of New York - Upstate Medical University** · enrollment: 60 (actual)

## Conditions studied

- Rabies

## Interventions

- **DRUG:** Rabies vaccine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02374814
- **Lead sponsor:** State University of New York - Upstate Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-03-24
- **Primary completion:** 2016-09-22
- **Final completion:** 2016-09-22
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2022-06-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02374814

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02374814, "Immunogenicity of Rabies Vaccine for Pre Exposure Prophylaxis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02374814. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*